Limits...
Focal therapy for prostate cancer: The current status.

Marshall S, Taneja S - Prostate Int (2015)

Bottom Line: Minimally invasive therapies are increasingly being investigated in localized prostate cancer.Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity.Long term studies are needed.

View Article: PubMed Central - PubMed

Affiliation: NYU Langone Medical Center, New York, NY, USA.

ABSTRACT

Purpose: In an era of increasing prostate cancer incidence and earlier detection, the assessment of clinical significance of prostate cancer is critical. Minimally invasive therapies are increasingly being investigated in localized prostate cancer.

Methods and results: In this review, we discuss the current status of magnetic resonance imaging targeted fusion prostate biopsy and focal therapy for prostate cancer, its rationale, and techniques.

Conclusion: Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity. Long term studies are needed.

No MeSH data available.


Related in: MedlinePlus

Focal laser ablation 3T MRI: same patient after laser ablation. T2-weighted image (left), apparent diffusion coefficient map (middle), and subtracted DCE (right). Lesion no longer seen. Small cavity on DCE (arrow). DCE, dynamic contrast enhancement.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494637&req=5

fig6: Focal laser ablation 3T MRI: same patient after laser ablation. T2-weighted image (left), apparent diffusion coefficient map (middle), and subtracted DCE (right). Lesion no longer seen. Small cavity on DCE (arrow). DCE, dynamic contrast enhancement.


Focal therapy for prostate cancer: The current status.

Marshall S, Taneja S - Prostate Int (2015)

Focal laser ablation 3T MRI: same patient after laser ablation. T2-weighted image (left), apparent diffusion coefficient map (middle), and subtracted DCE (right). Lesion no longer seen. Small cavity on DCE (arrow). DCE, dynamic contrast enhancement.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494637&req=5

fig6: Focal laser ablation 3T MRI: same patient after laser ablation. T2-weighted image (left), apparent diffusion coefficient map (middle), and subtracted DCE (right). Lesion no longer seen. Small cavity on DCE (arrow). DCE, dynamic contrast enhancement.
Bottom Line: Minimally invasive therapies are increasingly being investigated in localized prostate cancer.Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity.Long term studies are needed.

View Article: PubMed Central - PubMed

Affiliation: NYU Langone Medical Center, New York, NY, USA.

ABSTRACT

Purpose: In an era of increasing prostate cancer incidence and earlier detection, the assessment of clinical significance of prostate cancer is critical. Minimally invasive therapies are increasingly being investigated in localized prostate cancer.

Methods and results: In this review, we discuss the current status of magnetic resonance imaging targeted fusion prostate biopsy and focal therapy for prostate cancer, its rationale, and techniques.

Conclusion: Focal therapy offers a promising outlook for prostate cancer treatment, with the goal of effectively achieving cancer control while minimizing morbidity. Long term studies are needed.

No MeSH data available.


Related in: MedlinePlus